![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » HemoSense Announces Filing of Registration Statement With SEC
HemoSense Announces Filing of Registration Statement With SEC
April 1, 2005
HemoSense announced its filing of a registration statement with the Securities and Exchange Commission (SEC) for a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range of the proposed offering have not yet been determined. The offering is expected to be made to the public as soon as practicable.
San Jose dBusinessNews (http://sanjose.dbusinessnews.com/shownews.php?newsid=18263&type_news=latest)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct